Capital Drilling Ltd Q&A: Q4 2018 Trading Update (LON:CAPD)
21 January 2019
West Pharmaceutical Services, Inc. (NYSE: WST) has been a stalwart in the healthcare sector, specializing in the design and manufacture of containment and delivery systems for injectable drugs. With a..
As the healthcare sector continues to evolve, Option Care Health, Inc. (NASDAQ: OPCH) stands out as a key player in the medical care facilities industry. With a market capitalization of..
Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector, with its innovative approach to treating central nervous system (CNS) disorders. As the company continues to develop and..
Alkermes plc (NASDAQ: ALKS), a prominent player in the biopharmaceutical industry, presents an intriguing opportunity for investors with a substantial 28.11% potential upside based on current analyst target prices. As..
AptarGroup, Inc. (NYSE: ATR) presents a compelling opportunity in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $8.41 billion, AptarGroup stands out..
Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is drawing attention from investors seeking robust growth opportunities in the healthcare industry. With a market capitalization of $11.66..
Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector, stands out for its robust service offerings in diagnostics and research. With a market capitalization of $14.87 billion,..
Investors looking to navigate the volatile seas of biotechnology have a compelling opportunity in Insmed Incorporated (NASDAQ: INSM), a company that has garnered unanimous bullish sentiment from analysts. Specializing in..
Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, is a company worth a closer look for investors interested in the healthcare sector. With a market..
Teleflex Incorporated (NYSE: TFX), a prominent player in the medical instruments and supplies industry, has been attracting attention from investors due to its solid presence in the healthcare sector. With..
Elanco Animal Health Incorporated (NYSE: ELAN) is capturing investor attention with its strong buy ratings and substantial growth potential, reflecting a promising outlook for the company. With a market capitalization..
Moderna, Inc. (NASDAQ: MRNA) has made headlines since the onset of the COVID-19 pandemic, leveraging its mRNA technology to become a household name. However, as the pandemic’s urgency wanes, the..
Revvity, Inc. (RVTY), a notable player in the healthcare diagnostics and research sector, presents a compelling opportunity for investors seeking exposure to the healthcare industry. With its recent rebranding from..
BioNTech SE (NASDAQ: BNTX), a recognized leader in biotechnology based in Germany, has been making waves in the healthcare sector with its pioneering work in immunotherapy and mRNA technology. With..
HealthEquity, Inc. (NASDAQ: HQY), a leader in the Health Information Services industry, is capturing investor attention with its promising growth potential and dominant position in the healthcare sector. With a..
Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, is capturing investor attention with its robust market position and potential for a 14.17% upside. As a leading provider..
Biogen Inc. (BIIB), a prominent player in the healthcare sector, stands out in the drug manufacturing industry despite facing recent headwinds. With a market capitalization of $26.03 billion, Biogen is..
Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, is capturing investor attention with its potential upside of 24.14%, as suggested by analysts’ target prices. This potential growth..
Investors looking to explore opportunities in the healthcare sector might find Chemed Corp (NYSE: CHE) an intriguing prospect. With its diverse business operations spanning hospice care and plumbing services, Chemed..
Summit Therapeutics Inc. (NASDAQ: SMMT) has caught the attention of investors in the biotech sector, thanks to its promising pipeline and potential upside of 23.70%. Let’s delve into the various..
